Telesforo Bacchella

Telesforo Bacchella

Auto-generated profile, based on publicly available information

Telesforo Bacchella

Univesidade de São Paulo, Faculty of Medicine, Brazil

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2004 in Transplantation Proceedings
Verified
Journal Article
Closed access
TBT Bacchella
T Bacchella
EFE.R.R Figueira
E.R.R Figueira
FMF.F Makdissi
F.F Makdissi
VRV Rocha-Santos
V Rocha-Santos
RMR.B Martino
R.B Martino
MMMarcel c c Machado
Marcel c c Machado

1 June 1998 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
PDF file
JJJ. Jukemura
J. Jukemura
JCJ.E.M. da Cunha
J.E.M. da Cunha
SPS. Penteado
S. Penteado
TBT. Bacchella
T. Bacchella
EAE.E. Abdo
E.E. Abdo
HPH.W. Pinotti
H.W. Pinotti
After establishing the diagnosis of an insulinoma the next step is its localization in order to perform the most suitable management approach. To evaluate the methods used for the diagnosis of insulinoma and the localization of its site as well as the results of the surgical treatment. Fifty nine consecutive patients with pancreatic insulinomas were studied. The discriminative power of the preoperative investigations in the localization of insulinomas was analysed. Special attention was focused to the intra operative methods of tumor localizations. The early and late results of the surgical treatment were also investigated. There were 55 benign cases and 4 malignant tumors. Preoperative localization was attempted by using ultrasonography (positive in 28.1%) CT imaging (positive in 25%), selective arteriography (positive in 54.1%), endoscopic ultrasonography (positive in 27.2%) and assay of portal plasma insulin levels (positive in 94.4%). In 54/55 cases (98.2%) the tumors were identified intraoperatively by palpation. By addition of intraoperative ultrasonography all lesions were identified and successfully removed without mortality. Five patients had multiple endocrine neoplasias all with multiple lesions in the pancreas. In patients with benign lesions 29 enucleations and 32 resections were performed. Pancreatic fistulas were the most common complication (29/59). Excluding the patients with malignant lesions the recovery rate was 98.1%. Three patients who underwent corporo caudal pancreactectomy developed diabetes. The preoperative localization is not necessary, since a combination of palpation and intraoperative ultrasonography can deal with most cases. Enucleation when possible is the best choice for benign lesions.

1 January 2023 in ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
Verified
Journal Article
Open access
PDF file
RJRicardo Jureidini
Ricardo Jureidini
GNGuilherme Naccache Namur
Guilherme Naccache Namur
TRThiago Costa Ribeiro
Thiago Costa Ribeiro
TBTelesforo Bacchella
Telesforo Bacchella
LSLucas Stolzemburg
Lucas Stolzemburg
ICIvan Cecconello
Ivan Cecconello
BACKGROUND: Minimally invasive distal pancreatectomy (MIDP) is associated with less blood loss and faster functional recovery. However, the benefits of robotic assisted distal pancreatectomy (RDP) over laparoscopic distal pancreatectomy (LDP) are unknown. AIMS: To compare RDP versus LDP for surgical treatment of benign lesions, pre-malignant and borderline malignant pancreatic neoplasias. METHODS: This is a retrospective study comparing LDP with RDP. Main outcomes were overall morbidity and overall costs. Secondary outcomes were pancreatic fistula (PF), infectious complications, readmission, operative time (OT) and length of hospital stay (LOS). RESULTS: Thirty patients submitted to LDP and 29 submitted to RDP were included in the study. There was no difference regarding preoperative characteristics. There was no difference regarding overall complications (RDP – 72,4% versus LDP – 80%, p=0,49). Costs were superior for patients submitted to RDP (RDP=US$ 6,688 versus LDP=US$ 6,149, p=0,02), mostly due to higher costs of surgical materials (RDP=US$ 2,364 versus LDP=1,421, p=0,00005). Twenty-one patients submitted to RDP and 24 to LDP developed pancreatic fistula (PF), but only 4 RDP and 7 LDP experienced infectious complications associated with PF. OT (RDP=224 min. versus LDP=213 min., p=0.36) was similar, as well as conversion to open procedure (1 RDP and 2 LDP). CONCLUSIONS: The postoperative morbidity of robotic distal pancreatectomy is comparable to laparoscopic distal pancreatectomy. However, the costs of robotic distal pancreatectomy are slightly higher.

1 January 2007 in Clinics
Verified
Journal Article
Open access
PDF file
WAWellington Andraus
Wellington Andraus
ÊAÊnio Campos Amico
Ênio Campos Amico
MMMarcel Autran Machado
Marcel Autran Machado
TBTelésforo Bacchella
Telésforo Bacchella
MMMarcel c c Machado
Marcel c c Machado

1 May 2004 in Transplantation Proceedings
Verified
Journal Article
Closed access
DMD.M Medeiros
D.M Medeiros
Ana Cristina Mendes-OliveiraAna Cristina Mendes-Oliveira
Ana Cristina Mendes-Oliveira
MBM.F.A Barros
M.F.A Barros
RCR.A Cury
R.A Cury
HSH Sette-Junior
H Sette-Junior
MMMarcel c c Machado
Marcel c c Machado

1 January 2003 in Revista Do Hospital Das Clinicas
Verified
Journal Article
Open access
PDF file
HJHoel Sette Jr.
Hoel Sette Jr.
TBTelesforo Bacchella
Telesforo Bacchella
MMMarcel c c Machado
Marcel c c Machado
Liver transplantation is now the standard treatment for end-stage liver disease. Given the shortage of liver donors and the progressively higher number of patients waiting for transplantation, improvements in patient selection and optimization of timing for transplantation are needed. Several solutions have been suggested, including increasing the donor pool; a fair policy for allocation, not permitting variables such as age, gender, and race, or third-party payer status to play any role; and knowledge of the natural history of each liver disease for which transplantation is offered. To observe ethical rules and distributive justice (guarantee to every citizen the same opportunity to get an organ), the "sickest first" policy must be used. Studies have demonstrated that death has no relationship with waiting time, but rather with the severity of liver disease at the time of inclusion. Thus, waiting time is no longer part of the United Network for Organ Sharing distribution criteria. Waiting time only differentiates between equally severely diseased patients. The authors have analyzed the waiting list mortality and 1-year survival for patients of the State of São Paulo, from July 1997 through January 2001. Only the chronological criterion was used. According to "Secretaria de Estado da Saúde de São Paulo" data, among all waiting list deaths, 82.2% occurred within the first year, and 37.6% within the first 3 months following inclusion. The allocation of livers based on waiting time is neither fair nor ethical, impairs distributive justice and human rights, and does not occur in any other part of the world.